| Title： | Guidelines for the diagnosis and treatment of type I interferonopathies |
| Edition： | Original |
| Classification： | Standard guideline |
| Field： | Diagnosis and Treatment |
| Countries and regions： | China |
| Guidelines users： | It is applicable to all medical and health professionals and other staff of medical institutions. |
| Evidence classification method： | GRADE |
| Development unit： | Peking Union Medical College Hospital, Chinese Academy of Medical Sciences; Alliance for Pediatric Rheumatic and immune diseases; Rare Disease Medication Working Committee of China Pharmacists Association; Immunology Group of Chinese Pediatric Society, Chinese Medical Association |
| Registration time: | 2022-10-25 |
| Registration number： | PREPARE-2022CN674 |
| Purpose of the guideline: |
